Carlos Trujillo
Finanzdirektor/CFO bei PHARMACYTE BIOTECH, INC.
Vermögen: 22 048 $ am 30.04.2024
Aktive Positionen von Carlos Trujillo
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| PHARMACYTE BIOTECH, INC. | Finanzdirektor/CFO | 01.03.2017 | - |
| Direktor/Vorstandsmitglied | 01.03.2017 | 15.08.2022 |
Karriereverlauf von Carlos Trujillo
Ehemalige bekannte Positionen von Carlos Trujillo
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| VELATEL GLOBAL COMMUNICATIONS INC | Finanzdirektor/CFO | 01.06.2008 | 01.09.2014 |
| California Cove Communities, Inc. | Finanzdirektor/CFO | 01.01.2008 | 01.01.2008 |
Viridis Biotech, Inc.
 Viridis Biotech, Inc. Pharmaceuticals: MajorHealth Technology Part of PharmaCyte Biotech, Inc., Viridis Biotech, Inc. develops biopharmaceutical products for the treatment of chronic diseases. The company is based in Silver Spring, MD. The CEO of the company is Timothy M. Matula. | Finanzdirektor/CFO | 01.01.2015 | - |
Ausbildung von Carlos Trujillo
| California State University-Fullerton | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
Operativ
| Director of Finance/CFO | 4 |
| Undergraduate Degree | 1 |
| Director/Board Member | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
| Communications | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PHARMACYTE BIOTECH, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
VelaTel Global Communications, Inc.
 VelaTel Global Communications, Inc. Specialty TelecommunicationsCommunications VelaTel Global Communications, Inc. provides capital, engineering, architectural and construction services related to the build-out of wireless broadband telecommunications networks, which it then operates by offering services attractive to residential, enterprise and government subscribers. Its focus is on the deployment of telecommunications networks that utilize Wireless Broadband Access in emerging international markets. The company was founded on September 19, 2005 and is headquartered in Carlsbad, CA. | Communications |
| California Cove Communities, Inc. | |
Viridis Biotech, Inc.
Viridis Biotech, Inc. Pharmaceuticals: MajorHealth Technology Part of PharmaCyte Biotech, Inc., Viridis Biotech, Inc. develops biopharmaceutical products for the treatment of chronic diseases. The company is based in Silver Spring, MD. The CEO of the company is Timothy M. Matula. | Health Technology |
- Börse
- Insiders
- Carlos Trujillo
- Erfahrung
